Abstract
Metalloproteinases have been implicated in the cleavage of a number of cell surface immune receptors. Oral administration of the metalloproteinase inhibitor GI5402 attenuated the release of soluble CD27 and CD16 into the circulation after intravenous endotoxin injection in healthy humans.
MeSH Terms
Adult
Enzyme Inhibitors/administration & dosage,pharmacology
Health Status
Humans
Lipopolysaccharides/administration & dosage,immunology
Male
Matrix Metalloproteinase Inhibitors
Matrix Metalloproteinases/immunology
Receptors, IgG/biosynthesis
Solubility
Tumor Necrosis Factor Receptor Superfamily, Member 7/biosynthesis
Chemicals
Enzyme Inhibitors
Lipopolysaccharides
Matrix Metalloproteinase Inhibitors
Receptors, IgG
Tumor Necrosis Factor Receptor Superfamily, Member 7
Matrix Metalloproteinases
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Dekkers P E
Laboratory of Experimental Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. P.E.Dekkers@AMC.UVA.NL
ten Hove T
Lauw F N
Koene H R
Lumley P
van Deventer S J
van der Poll T
References (19)
19 references, click to expand
-
Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen.
J Immunol. 1987 Sep 1;139(5):1589-96
PMID: 2442250
-
The effect of a metalloproteinase inhibitor (GI5402) on tumor necrosis factor-alpha (TNF-alpha) and TNF-alpha receptors during human endotoxemia.
Blood. 1999 Oct 1;94(7):2252-8
PMID: 10498596
-
Soluble Fc gamma receptor III in human plasma originates from release by neutrophils.
J Clin Invest. 1990 Aug;86(2):416-23
PMID: 2166753
-
Regulation of expression of CD27, a T cell-specific member of a novel family of membrane receptors.
J Immunol. 1991 Apr 15;146(8):2488-94
PMID: 1707907
-
A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex.
J Immunol. 1991 Jul 1;147(1):29-35
PMID: 1646845
-
The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis.
Eur J Immunol. 1992 Feb;22(2):447-55
PMID: 1311261
-
Expression and release of CD27 in human B-cell malignancies.
Blood. 1993 Dec 1;82(11):3430-6
PMID: 8241510
-
Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing.
Nature. 1994 Jul 21;370(6486):218-20
PMID: 8028669
-
Processing of tumour necrosis factor-alpha precursor by metalloproteinases.
Nature. 1994 Aug 18;370(6490):555-7
PMID: 8052310
-
Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor.
Nature. 1994 Aug 18;370(6490):558-61
PMID: 8052311
-
Fc gamma receptors of phagocytes.
J Lab Clin Med. 1995 Oct;126(4):330-41
PMID: 7561440
-
NA-phenotype-dependent differences in neutrophil Fc gamma RIIIb expression cause differences in plasma levels of soluble Fc gamma RIII.
Br J Haematol. 1996 Apr;93(1):235-41
PMID: 8611467
-
The tumor necrosis factor ligand and receptor families.
N Engl J Med. 1996 Jun 27;334(26):1717-25
PMID: 8637518
-
Down-regulation of surface receptors for TNF and IL-1 on circulating monocytes and granulocytes during human endotoxemia: effect of neutralization of endotoxin-induced TNF activity by infusion of a recombinant dimeric TNF receptor.
J Immunol. 1997 Feb 1;158(3):1490-7
PMID: 9013996
-
Membrane protein secretases.
Biochem J. 1997 Jan 15;321 ( Pt 2):265-79
PMID: 9020855
-
Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans.
Blood. 1997 Aug 15;90(4):1415-24
PMID: 9269759
-
Involvement of a metalloprotease in the shedding of human neutrophil Fc gammaRIIIB.
FEBS Lett. 1997 Sep 1;414(1):14-8
PMID: 9305723
-
Control of lymphocyte function through CD27-CD70 interactions.
Semin Immunol. 1998 Dec;10(6):491-9
PMID: 9826582
-
The PI-linked receptor FcRIII is released on stimulation of neutrophils.
Nature. 1988 Jun 16;333(6174):667-9
PMID: 2967437